NCT07152210View on ClinicalTrials.gov

Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Colorectal Cancer (CRC)

Interventions

BIOLOGICAL

CAR-T

Eligible subjects who successfully passed screening will receive CAR-T cell infusion on Day 0 after lymphodepleting preconditioning chemotherapy.

Trial Locations (1)

523125

RECRUITING

Dongguan Taixin Hospital, Dongguan

All Listed Sponsors

lead

Guangzhou Bio-gene Technology Co., Ltd

INDUSTRY

NCT07152210 - Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter